Kaia Health Raises $10M Series A To Scale Its Back Pain Therapy App In The U.S.

Funding Rounds

Summary

Made of mere flesh and bone, us humans need a lot of maintenance to maintain full functionality. While hands-on, one-on-one attention and ongoing patient follow-up is an ideal to strive for, a new wave of “digital therapeutics“ is there to bridge the gap in care, especially for chronic conditions. Based in Munich, Germany, the digital therapeutics upstart raised $10 million in a Series A round led by Balderton Capital. The Series A check is earmarked for the company’s broader rollout in the U.S., which includes opening an office in New York City. Kaia Health says that its home-based digital therapeutic technology is “a clinically-validated alternative to painkillers, delivered through a smartphone.” Given the rising human and economic costs of the opioid crisis in the U.S., which according to the NIH claimed over 72,000 lives in 2017, an option besides physical therapy (which can be expensive without insurance) and painkillers (which can be addictive) may come as a welcome relief for many.

$ Funding

$
Amount $10.0M Total raised
Date January 21, 2019 Announcement date
Investors The National Institute on Drug Abuse Lead investors
Company http://www.kaia-health.com Funded company

Classifications

industries
No industries detected
applications
Accounting and Taxes

AskAI Classifications

Labels
Digital Health Healthcare Software SaaS

Linked Companies

Kaia Health
$1M to $5M